{"id":368864,"date":"2025-12-05T14:00:46","date_gmt":"2025-12-05T08:30:46","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=368864"},"modified":"2025-12-05T14:58:45","modified_gmt":"2025-12-05T09:28:45","slug":"sam-advises-eris-lifesciences-acquisition-swiss-parenterals","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","title":{"rendered":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited"},"content":{"rendered":"
\n

New Delhi | December 4th, 2025:<\/span> Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of Swiss Parenterals Limited (“SPL”) (in which ELL currently holds 70% of the share capital) from Mr. Naishadh Shah (Director, SPL), for an aggregate consideration of INR 423.30 crores. The consideration will be discharged by ELL by way of issuance of equity shares of ELL to Mr. Naishadh Shah, on a preferential basis.<\/p>\n

Upon completion of the proposed acquisition, subject to receipt of necessary stock exchange approvals, SPL will become a wholly owned subsidiary of ELL.<\/p>\n

The SAM transaction team was led by Nivedita Tiwari, Partner, and Devesh Pandey, Partner, along with Kuhuk Jain, Principal Associate; Anushka Ganguli, Associate; and Sourav Paul, Associate.<\/p>\n

Gouri Puri, Partner, Rahul Yadav, Partner and Nimish Malpani, Principal Associate advised ELL on the tax related aspects pertaining to the transaction.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals, making it a wholly owned subsidiary.<\/p>\n","protected":false},"author":67011,"featured_media":368884,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[94175,94171,94169,92873,94176,94174,94172,46701,94173,94170],"class_list":["post-368864","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-corporate-transaction-india","tag-ell-spl-acquisition","tag-eris-lifesciences-acquisition","tag-ma-law-firms-india","tag-pharma-sector-acquisition","tag-preferential-allotment-india","tag-sam-legal-advisory","tag-shardul-amarchand-mangaldas","tag-share-purchase-india","tag-swiss-parenterals-deal"],"yoast_head":"\nSAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times<\/title>\n<meta name=\"description\" content=\"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited\" \/>\n<meta property=\"og:description\" content=\"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-05T08:30:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-05T09:28:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/\",\"name\":\"SAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp\",\"datePublished\":\"2025-12-05T08:30:46+00:00\",\"dateModified\":\"2025-12-05T09:28:45+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp\",\"width\":886,\"height\":590,\"caption\":\"Eris Lifesciences Swiss Parenterals acquisition\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times","description":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","og_description":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-12-05T08:30:46+00:00","article_modified_time":"2025-12-05T09:28:45+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","name":"SAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","datePublished":"2025-12-05T08:30:46+00:00","dateModified":"2025-12-05T09:28:45+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","width":886,"height":590,"caption":"Eris Lifesciences Swiss Parenterals acquisition"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":369143,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/08\/cam-advises-swiss-parenterals-30-percent-stake-acquisition-eris-lifesciences-2025\/","url_meta":{"origin":368864,"position":0},"title":"Cyril Amarchand Mangaldas advises Swiss Parenterals Limited in acquisition of its 30% stake by Eris Lifesciences Limited","author":"Editor","date":"December 8, 2025","format":false,"excerpt":"Cyril Amarchand Mangaldas advised Swiss Parenterals Limited and its promoter on the sale of the remaining 30% stake to Eris Lifesciences Limited through a preferential allotment deal worth \u20b9423.30 crore.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Swiss Parenterals Eris Lifesciences acquisition","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Swiss-Parenterals-Eris-Lifesciences-acquisition.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":315201,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/02\/24\/shardul-amarchand-mangaldas-co-advises-eris-lifesciences-limited-on-the-acquisition-of-a-majority-stake-in-swiss-parenterals-limited\/","url_meta":{"origin":368864,"position":1},"title":"Shardul Amarchand Mangaldas & Co. advises Eris Lifesciences Limited on the acquisition of a majority stake in Swiss Parenterals Limited","author":"Bhumika Indulia","date":"February 24, 2024","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on the acquisition of a majority stake in Swiss Parenterals Limited (\u201cSPL\u201d) from the existing shareholders of SPL by Eris and certain individual purchasers. The aggregate deal value is approximately INR 875 Crores (USD 105.38 million). The consideration was paid through a\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/02\/Eris-Lifesciences-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":308625,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/12\/07\/sam-advises-eris-lifesciences-limited-acquisition-of-dermatology-and-nephrology-branded-formulations-business-units\/","url_meta":{"origin":368864,"position":2},"title":"SAM advises Eris Lifesciences Limited on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"December 7, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (\u201cBiocon\u201d) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023. This acquisition marks the\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":292287,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/05\/16\/shardul-amarchand-mangaldas-advises-macquarie-capital-in-its-acquisition-of-majority-stake-in-excel-telesonic-india-private-limited-cloudextel\/","url_meta":{"origin":368864,"position":3},"title":"Shardul Amarchand Mangaldas advises Macquarie Capital in its acquisition of majority stake in Excel Telesonic India Private Limited (CloudExtel)","author":"Bhumika Indulia","date":"May 16, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas & Co. advised Macquarie Capital, the corporate advisory, capital markets, and principal investment arm of Macquarie Group, in its acquisition of majority stake in Excel Telesonic India Private Limited (CloudExtel), a leading Network as a Service (NaaS) provider in India. Shardul Amarchand Mangaldas & Co. advised on\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"shardul amarchand mangaldas","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/shardul-amarchand-mangaldas.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":290510,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/04\/25\/shardul-amarchand-mangaldas-advises-birla-estates-private-limited-on-acquisition-of-land-and-building-in-south-mumbai\/","url_meta":{"origin":368864,"position":4},"title":"Shardul Amarchand Mangaldas advises Birla Estates Private Limited on acquisition of land and building in South Mumbai","author":"Bhumika Indulia","date":"April 25, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas & Co. advised Birla Estates Private Limited on its acquisition of land and building at Walkeshwar, Malabar Hill Division, Mumbai. The transaction is undertaken with the intention of developing a premium residential project. The SAM & Co. team assisted on all the legal aspects of the transaction,\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"birla estates private limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/birla-estates-private-limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/birla-estates-private-limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/birla-estates-private-limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/birla-estates-private-limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":287398,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/03\/21\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-a-part-of-the-dermatology-portfolio-of-dr-reddys-laboratories-limited\/","url_meta":{"origin":368864,"position":5},"title":"Khaitan & Co advises Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy’s Laboratories Limited","author":"Bhumika Indulia","date":"March 21, 2023","format":false,"excerpt":"Khaitan & Co has advised Eris Lifesciences Limited on its acquisition of a part of the dermatology portfolio of Dr. Reddy's Laboratories Limited for a total consideration of INR 275 crores. The acquisition helps augment and expand the dermatology business of Eris Lifesciences in India. The team assisted in drafting,\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/03\/MicrosoftTeams-image-811.png?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=368864"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368864\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/368884"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=368864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=368864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=368864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}